Antimicrobial Stewardship & Healthcare Epidemiology (Jan 2023)

Penicillin allergy evaluation in hospitalized patients with hematologic malignancy

  • Vima M. Patel,
  • Brian Chu,
  • Keith W. Hamilton,
  • Cassandra Bellamy,
  • Christina Harker,
  • Joshua S. Bryer,
  • Bridget Shields,
  • Rebecca L. Hirsh,
  • Olajumoke O. Fadugba,
  • Robert G. Micheletti

DOI
https://doi.org/10.1017/ash.2023.144
Journal volume & issue
Vol. 3

Abstract

Read online

A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactams during follow-up. Providers found the PATS valuable.